Schedule 13G ownership disclosure

Harmony Biosciences Holdings Inc

Common Stock · CUSIP: 413197104

Event date: 2024-12-31

Filing-level shares
4,733,609
Percent of class
8.3%
  • The Vanguard Group

    Shares: 4,733,609 · Class: 8.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000168
Form type
SCHEDULE 13G/A
Filer
Harmony Biosciences Holdings, Inc.
CIK
CIK 1802665
Filed
Jan 30, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub